|
Radiation therapy: re-designing extent
and duration
Chair: D. Wazer
Rapporteur: B. Jereczek-Fossa |
| 8.15 |
Partial Breast Irradiation: gaining evidence
for proper use
D. Wazer |
| 8.30 |
Intraoperative Electron beams radiotherapy
(ELIOT)
R. Orecchia |
| 8.45 |
IART as a boost for accelerated breast
irradiation
G. Paganelli |
| 9.00 |
Radiotherapy in postmenopausal women after breast conserving surgery
C. Tinterri |
| 9.15 |
Discussion |
| 9.25 |
Spotlight:
Extending breast conservation:
oncoplastic surgery techniques and
indications.
K. Clough |
| |
Adjuvant systemic therapies:
tailored therapies for improved use
Chair: R. Gelber
Rapporteur: V. Bagnardi - L. Orlando |
| 9.45 |
Adjuvant therapies and expectations from
gene profiling
F. Cardoso |
| 10.00 |
Tailoring adjuvant therapies for tumours with
at least some endocrine responsiveness:
tumour and host characteristics & quality of
life considerations
A. S. Coates |
| 10.15 |
Chemotherapies for endocrine non
responsive disease
A. Di Leo |
| 10.30 |
Coffee Break |
| 11.00 |
Endocrine therapies for women with
endocrine responsive disease
R. Torrisi |
| 11.15 |
Is preoperative adjuvant treatment for
operable disease useful?
H. Burstein |
| 11.30 |
Discussion |
| 11.40 |
Spotlight:
Breast cancer cells and their growth factors: lessons on networking.
Y. Yarden |
| 12.00 |
The Milan Breast Cancer Observatory:
Innovation and care in the next 12 months
Participants: F. Cardoso, K. Clough,
A. Coates, A. Di Leo, A. Goldhirsch, E. Winer
Chair:A. Goldhirsch |
| 12.50 |
Lunch |
| |
Targeted treatments: facts and promises
Chair: E. Winer
Rapporteur: E. Munzone |
| 13.45 |
HER2 targeted therapy: current status
E. Perez |
| 14.00 |
Aiming at breast cancer cells: new targets
and new agents
E. Winer |
| 14.15 |
Angiogenesis as target for therapy for
advanced and operable breast cancer
F. Bertolini |
| 14.30 |
Using metronomic therapies to target cancer
continuously: challenging the concept of low
dose = induction of resistance
M. Colleoni |
| 14.45 |
Discussion |
| |
How to follow breast cancer survivors?
Chair: A. S. Coates
Rapporteur: R. Torrisi |
| 15.00 |
Follow up with clinical, laboratory and
imaging means: the necessary, the
reasonable and the useful
S. Ciatto |
| 15.15 |
Issues of life style and psychological
support for breast cancer survivors (by age group)
H. Burstein |
| 15.30 |
Discussion |
| 15.45 |
Coffee Break |
| |
The very young woman with breast
cancer
Chair: A. Partridge
Rapporteur: M. Locatelli |
| 16.15 |
Local control of disease
O. Gentilini |
| 16.30 |
Fertility issues and treatments for breast
cancer
A. Partridge |
| 16.45 |
Pregnancy and breast cancer
F. Peccatori |
| 17.00 |
Discussion and closing remarks |
